L

L&C Bio Co Ltd
KOSDAQ:290650

Watchlist Manager
L&C Bio Co Ltd
KOSDAQ:290650
Watchlist
Price: 57 000 KRW 5.56% Market Closed
Market Cap: ₩1.4T

Net Margin

97.5%
Current
Improving
by 18.3%
vs 3-y average of 79.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
97.5%
=
Net Income
₩78B
/
Revenue
₩80B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
97.5%
=
Net Income
₩78B
/
Revenue
₩80B

Peer Comparison

Country Company Market Cap Net
Margin
KR
L&C Bio Co Ltd
KOSDAQ:290650
1.4T KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
385B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.4B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
169B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.3B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.1B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.8B USD
Loading...

Market Distribution

Higher than 99% of companies in Korea
Percentile
99th
Based on 2 632 companies
99th percentile
97.5%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

L&C Bio Co Ltd
Glance View

Market Cap
1.4T KRW
Industry
Biotechnology

L&C BIO Co., Ltd. develops soft tissue, allografts, and medical devices. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-11-01. The firm mainly manufactures and sells human tissue transplant materials used for tissue repair and filler. The firm also produces and sells human tissue-based medical devices and Cosmeceuticals. Its products are used in vascular surgeries, plastic surgeries, general surgeries and others.

Intrinsic Value
16 131.84 KRW
Overvaluation 72%
Intrinsic Value
Price
L
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
97.5%
=
Net Income
₩78B
/
Revenue
₩80B
What is L&C Bio Co Ltd's current Net Margin?

The current Net Margin for L&C Bio Co Ltd is 97.5%, which is above its 3-year median of 79.3%.

How has Net Margin changed over time?

Over the last 3 years, L&C Bio Co Ltd’s Net Margin has increased from 22% to 97.5%. During this period, it reached a low of -8.5% on Sep 30, 2024 and a high of 195.7% on Dec 31, 2024.

Back to Top